BIOA
BioAge Labs (BIOA) Faces Securities Class Action On Behalf Of IPO Investors After Discontinuing Weight-Loss Drug Trial– Hagens Berman
SAN FRANCISCO, Feb. 10, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is...
Read moreDetails
Class Action Filed Against BioAge Labs, Inc. (BIOA) Seeking Recovery for Investors – Contact Levi & Korsinsky
NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. ("BioAge" or...
Read moreDetails
BIOA Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Shareholders of Securities Fraud Class Action Lawsuit Deadline
RADNOR, Pa., Feb. 10, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs...
Read moreDetails
BIOA CLASS ACTION ALERT: A Class Action has been filed on behalf of BioAge Labs Investors – Contact BFA Law by March 10 (NASDAQ:BIOA)
NEW YORK, Feb. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a...
Read moreDetails
Lost Money on BioAge Labs, Inc.(BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky
NEW YORK, Feb. 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in BioAge Labs, Inc. ("BioAge" or...
Read moreDetails
BioAge Labs (BIOA) Shares Plummet After Discontinuing Trial Just 2 Months After IPO– Hagens Berman
SAN FRANCISCO, Feb. 07, 2025 (GLOBE NEWSWIRE) -- BioAge Labs (NASDAQ: BIOA), a biopharmaceutical company focused on metabolic diseases, is...
Read moreDetails
BioAge Labs, Inc. (BIOA) Investors: March 10, 2025 Filing Deadline in Securities Class Action – Contact Kessler Topaz Meltzer & Check, LLP
RADNOR, Pa., Jan. 26, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs...
Read moreDetails
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO , Jan. 11, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of...
Read moreDetails
BIOA CLASS ACTION ALERT: BioAge Labs Investors that Lost Money are Notified of a Class Action Lawsuit – Contact BFA Law by March 10 Legal Deadline (NASDAQ:BIOA)
NEW YORK, Jan. 11, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a...
Read moreDetails
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA
NEW YORK, Jan. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing...
Read moreDetails